Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1

Conditions

Multiple Myeloma 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Burkitt Lymphoma 25Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Mantle-Cell 7Leukemia, Biphenotypic, Acute 7Recurrence 6Immunoglobulin Light-chain Amyloidosis 6Vomiting 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Smoldering Multiple Myeloma 4Neoplasm Metastasis 4Nausea 4Leukemia 4Hodgkin Disease 4Breast Neoplasms 4Blast Crisis 4Plasmacytoma 3Ovarian Neoplasms 3Neoplasms 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Leukemia, Plasma Cell 3

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × dexamethasone 21-phosphate × Clear all
NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

NCT03367156 2025-11-12

Dexamethasone in Controlling Dyspnea in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
135 enrolled 19 charts
Other

Dyspnea, Neoplasms

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed
494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡